This product is a recombinant Human antibody that recognizes Triggering receptor expressed on myeloid cells-1. The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.
Figure 1 Anti-Human TREM1 Protein Antibody in ELISA
ELISA analysis of TAB-167CQ was performed by coating with Recombinant Human TREM1 Protein. Then blocked with BSA, and incubated with Anti-Human TREM1 Antibody (TAB-167CQ). The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 2 Anti-Human TREM1 Recombinant Antibody (TAB-167CQ) in SDS-PAGE
SDS-PAGE analysis of TAB-167CQ in non-reduced (Lane 1) and β-mercaptoethanol-reduced (Lane 2) conditions.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-2466-sdAb | Recombinant Anti-Human TREM1 VHH Single Domain Antibody | ICC, FC, WB, FUNC | Llama VHH |
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-167CQ, RRID: AB_3111845)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.